Apollo Hospitals Enterprise
- Home ›
- IN ›
- Healthcare
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The last earnings update was 225 days ago. More info.
Add to Portfolio Compare Print
APOLLOHOSP Share Price and Events
7 Day Returns
1 Year Returns
APOLLOHOSP Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise (APOLLOHOSP) | -3.6% | 7.1% | -6.5% | 12.9% | -6.7% | 37.4% |
| IN Healthcare | -1.9% | 0.7% | -2.5% | -6.6% | -10.2% | 41.3% |
| IN Market | -1.9% | 1.2% | 5.1% | -2.8% | 38.3% | 71% |
1 Year Return vs Industry and Market
- APOLLOHOSP outperformed the Healthcare industry which returned -6.6% over the past year.
- APOLLOHOSP outperformed the Market in India which returned -2.8% over the past year.
Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Apollo Hospitals Enterprise
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Apollo Hospitals Enterprise.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 15 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 15% |
| Perpetual Growth Rate | 10-Year IN Government Bond Rate | 7.6% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year IN Govt Bond Rate | 7.6% |
| Equity Risk Premium | S&P Global | 8.6% |
| Healthcare Unlevered Beta | Simply Wall St/ S&P Global | 0.72 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.715 (1 + (1- 35%) (19.84%)) |
0.871 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.87 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.55% + (0.871 * 8.6%) |
15.04% |
Discounted Cash Flow Calculation for NSEI:APOLLOHOSP using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Apollo Hospitals Enterprise is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (INR, Millions) | Source |
Present Value Discounted (@ 15.04%) |
|
|---|---|---|---|
| 2019 | 5,527.50 | Analyst x4 | 4,804.82 |
| 2020 | 5,817.45 | Analyst x6 | 4,395.72 |
| 2021 | 6,387.19 | Analyst x5 | 4,195.24 |
| 2022 | 6,949.58 | Est @ 8.8% | 3,967.83 |
| 2023 | 7,535.31 | Est @ 8.43% | 3,739.77 |
| 2024 | 8,150.56 | Est @ 8.16% | 3,516.25 |
| 2025 | 8,801.01 | Est @ 7.98% | 3,300.46 |
| 2026 | 9,492.00 | Est @ 7.85% | 3,094.20 |
| 2027 | 10,228.67 | Est @ 7.76% | 2,898.40 |
| 2028 | 11,016.03 | Est @ 7.7% | 2,713.39 |
| Present value of next 10 years cash flows | ₹36,626.09 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= ₹11,016.03 × (1 + 7.55%) ÷ (15.04% – 7.55%) |
₹158,167.60 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= ₹158,167.60 ÷ (1 + 15.04%)10 |
₹38,958.76 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= ₹36,626.09 + ₹38,958.76 |
₹75,584.85 |
| Equity Value per Share (INR) |
= Total value / Shares Outstanding
= ₹75,584.85 / 139.13 |
₹543.29 |
| Calculation | Result | |
|---|---|---|
| Value per share (INR) | From above. | ₹543.29 |
| Current discount | Discount to share price of
₹1,228.80
= -1 x (₹1,228.80 - ₹543.29) / ₹543.29 |
-126.2% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Apollo Hospitals Enterprise is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Apollo Hospitals Enterprise's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Apollo Hospitals Enterprise's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-03-31) in INR | ₹8.44 |
| NSEI:APOLLOHOSP Share Price ** | NSEI (2019-04-24) in INR | ₹1228.8 |
| India Healthcare Industry PE Ratio | Median Figure of 23 Publicly-Listed Healthcare Companies | 23.47x |
| India Market PE Ratio | Median Figure of 2,739 Publicly-Listed Companies | 16.02x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Apollo Hospitals Enterprise.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NSEI:APOLLOHOSP Share Price ÷ EPS (both in INR) = 1228.8 ÷ 8.44 |
145.6x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Apollo Hospitals Enterprise is overvalued based on earnings compared to the IN Healthcare industry average.
- Apollo Hospitals Enterprise is overvalued based on earnings compared to the India market.
Price based on expected Growth
Does
Apollo Hospitals Enterprise's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 145.6x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 15 Analysts |
42.7%per year |
| India Healthcare Industry PEG Ratio | Median Figure of 5 Publicly-Listed Healthcare Companies | 2.03x |
| India Market PEG Ratio | Median Figure of 586 Publicly-Listed Companies | 1.32x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 145.6x ÷ 42.7% |
3.41x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Apollo Hospitals Enterprise is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on
Apollo Hospitals Enterprise's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-03-31) in INR | ₹233.71 |
| NSEI:APOLLOHOSP Share Price * | NSEI (2019-04-24) in INR | ₹1228.8 |
| India Healthcare Industry PB Ratio | Median Figure of 33 Publicly-Listed Healthcare Companies | 1.97x |
| India Market PB Ratio | Median Figure of 3,630 Publicly-Listed Companies | 1.09x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NSEI:APOLLOHOSP Share Price ÷ Book Value per Share (both in INR) = 1228.8 ÷ 233.71 |
5.26x |
* Primary Listing of Apollo Hospitals Enterprise.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Apollo Hospitals Enterprise is overvalued based on assets compared to the IN Healthcare industry average.
Value checks
We assess Apollo Hospitals Enterprise's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check) Apollo Hospitals Enterprise has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Apollo Hospitals Enterprise's earnings growth is expected to exceed the low risk savings rate of 7.6%.
Growth vs Market Checks
- Apollo Hospitals Enterprise's earnings growth is expected to exceed the India market average.
- Apollo Hospitals Enterprise's revenue growth is expected to exceed the India market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NSEI:APOLLOHOSP Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 15 Analysts | 42.7% |
| NSEI:APOLLOHOSP Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 15 Analysts | 12.7% |
| India Healthcare Industry Earnings Growth Rate | Market Cap Weighted Average | 39.3% |
| India Healthcare Industry Revenue Growth Rate | Market Cap Weighted Average | 12.7% |
| India Market Earnings Growth Rate | Market Cap Weighted Average | 18.3% |
| India Market Revenue Growth Rate | Market Cap Weighted Average | 11.7% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 year ago) | See Below |
| Future Estimates | Average of up to 15 Analyst Estimates (S&P Global) | See Below |
| Date (Data in INR Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2024-03-31 | 240,000 | 1 | ||
| 2023-03-31 | 210,000 | 1 | ||
| 2022-03-31 | 182,000 | 1 | ||
| 2021-03-31 | 122,008 | 10,278 | 5,464 | 15 |
| 2020-03-31 | 107,791 | 9,202 | 4,117 | 15 |
| 2019-03-31 | 95,075 | 5,110 | 2,666 | 15 |
| Date (Data in INR Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-03-31 | 82,435 | 5,370 | 1,174 |
| 2017-03-31 | 72,557 | 6,226 | 2,210 |
| 2016-03-31 | 62,147 | 5,972 | 2,364 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 year ago) | See Below |
| Future Estimates | Average of up to 15 Analyst Estimates (S&P Global) | See Below |
All data from Apollo Hospitals Enterprise Company Filings, last reported 1 year ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in INR Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2024-03-31 | ||||
| 2023-03-31 | ||||
| 2022-03-31 | ||||
| 2021-03-31 | 38.04 | 47.90 | 25.78 | 10.00 |
| 2020-03-31 | 28.55 | 38.80 | 19.90 | 11.00 |
| 2019-03-31 | 19.53 | 23.30 | 13.77 | 11.00 |
| Date (Data in INR Millions) | EPS * |
|---|---|
| 2018-03-31 | 8.44 |
| 2017-03-31 | 15.88 |
| 2016-03-31 | 16.99 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Apollo Hospitals Enterprise is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
Future performance checks
We assess Apollo Hospitals Enterprise's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Apollo Hospitals Enterprise has a total score of 4/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has Apollo Hospitals Enterprise performed over the past 5 years?
- Apollo Hospitals Enterprise's last earnings update was 225 days ago.
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Insufficient data to establish if Apollo Hospitals Enterprise's year on year earnings growth rate was positive over the past 5 years.
- Apollo Hospitals Enterprise's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Apollo Hospitals Enterprise's 1-year earnings growth is negative, it can't be compared to the IN Healthcare industry average.
Earnings and Revenue History
All data from Apollo Hospitals Enterprise Company Filings, last reported 1 year ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in INR Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-03-31 | 82,434.68 | 1,174.18 | 5,180.92 | |
| 2017-03-31 | 72,557.03 | 2,209.90 | 4,740.16 | |
| 2016-03-31 | 62,146.54 | 2,363.80 | 4,466.58 | |
| 2015-03-31 | 51,784.53 | 3,399.03 | 3,606.18 | |
| 2014-03-31 | 43,842.21 | 3,167.45 | 5,397.63 | |
| 2013-03-31 | 37,988.80 | 3,043.50 | 4,473.31 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Apollo Hospitals Enterprise has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Apollo Hospitals Enterprise used its assets less efficiently than the IN Healthcare industry average last year based on Return on Assets.
- Apollo Hospitals Enterprise's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Apollo Hospitals Enterprise's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Apollo Hospitals Enterprise has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is Apollo Hospitals Enterprise's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Apollo Hospitals Enterprise's finances.
The net worth of a company is the difference between its assets and liabilities.
- Apollo Hospitals Enterprise is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Apollo Hospitals Enterprise's long term commitments exceed its cash and other short term assets.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is not covered by short term assets, assets are 0.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Apollo Hospitals Enterprise Company Filings, last reported 1 year ago.
| Date (Data in INR Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-03-31 | 33,839.42 | 34,310.08 | 3,642.06 |
| 2017-03-31 | 34,377.77 | 31,252.92 | 3,886.27 |
| 2016-03-31 | 34,090.63 | 28,370.85 | 4,237.16 |
| 2015-03-31 | 32,443.46 | 19,922.58 | 5,229.03 |
| 2014-03-31 | 29,954.63 | 13,443.58 | 4,296.48 |
| 2013-03-31 | 27,641.17 | 11,367.77 | 6,988.23 |
- Apollo Hospitals Enterprise's level of debt (101.4%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has increased over the past 5 years (41.1% vs 101.4% today).
- Debt is not well covered by operating cash flow (15.7%, less than 20% of total debt).
- Interest payments on debt are not well covered by earnings (EBIT is 1.8x annual interest expense, ideally 3x coverage).
Financial health checks
We assess Apollo Hospitals Enterprise's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Apollo Hospitals Enterprise has a total score of 1/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is Apollo Hospitals Enterprise's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
₹2,000 of
Apollo Hospitals Enterprise
shares you are expected to receive
₹8
in your first year as a dividend.
Dividend Amount
- Apollo Hospitals Enterprise's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.51%).
- Apollo Hospitals Enterprise's dividend is below the markets top 25% of dividend payers in India (1.95%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 15 Analyst Estimates (S&P Global) | See Below |
| India Healthcare Industry Average Dividend Yield | Market Cap Weighted Average of 10 Stocks | 0.7% |
| India Market Average Dividend Yield | Market Cap Weighted Average of 1400 Stocks | 1.4% |
| India Minimum Threshold Dividend Yield | 10th Percentile | 0.3% |
| India Bottom 25% Dividend Yield | 25th Percentile | 0.5% |
| India Top 25% Dividend Yield | 75th Percentile | 2% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in ₹) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2024-03-31 | ||
| 2023-03-31 | ||
| 2022-03-31 | ||
| 2021-03-31 | 9.21 | 10.00 |
| 2020-03-31 | 7.82 | 11.00 |
| 2019-03-31 | 7.01 | 12.00 |
| Date (Data in ₹) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2018-05-30 | 5.000 | 0.442 |
| 2017-05-30 | 6.000 | 0.532 |
| 2016-03-15 | 6.000 | 0.468 |
| 2015-05-28 | 5.750 | 0.422 |
| 2014-05-28 | 5.750 | 0.498 |
| 2013-05-20 | 5.500 | 0.604 |
| 2012-05-29 | 4.000 | 0.538 |
| 2011-07-14 | 3.750 | 0.661 |
| 2011-05-24 | 3.750 | 0.774 |
| 2010-05-28 | 3.500 | 0.782 |
| 2009-06-29 | 3.250 | 1.066 |
| 2009-06-01 | 3.250 | 1.258 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Dividends per share have been stable in the past 10 years.
- Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of
Apollo Hospitals Enterprise's earnings are
paid
to the shareholders as a dividend.
- Dividends paid are covered by earnings (1.7x coverage).
- Dividends after 3 years are expected to be well covered by earnings (4.1x coverage).
Income/ dividend checks
We assess Apollo Hospitals Enterprise's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Apollo Hospitals Enterprise afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Apollo Hospitals Enterprise has a total score of 4/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
CEO
| COMPENSATION | ₹38,220,000 |
| AGE | 59 |
| TENURE AS CEO | 4.8 years |
CEO Bio
Mrs. Suneeta Reddy has been Managing Director of Apollo Hospitals Enterprise Ltd. since July 2, 2014. Mrs. Reddy served as Joint Managing Director of Apollo Hospitals Enterprise Ltd. since February 3, 2011. She serves as Joint Managing Director of Apollo Sindoori Hotels Limited. She served as Joint Managing Director of the erstwhile Indian Hospitals Corporation Limited. Mrs. Reddy served as an Executive Director of Finance at Apollo Hospitals Enterprise Ltd., from May 2000 to May 31, 2011. She serves as the Chairperson of Aircel Cellular Limited. She served as Chairperson of Cellular Operators Association of India. She served as Chairperson and Director of Aditya Birla Money Limited until March 6, 2009. She serves as a Non-Executive Director of Apollo Sindoori Hotels Limited. She serves as a Director of Apollo Munich Health Insurance Company Limited. She has been a Non-Executive Director of Indraprastha Medical Corp. Ltd. since August 31, 2005. She has been an Executive Director at Apollo Hospitals Enterprise Ltd. since May 1, 2000. She serves as a Non-Executive Director of Apollo Hospitals International Limited, Apollo Sindoori Capital Investments Ltd., Apollo Mumbai Hospitals Limited, PCR Investments Limited, Apollo Health and Lifestyle Limited, Family Health Plan Limited, Apollo Gleneagles Hospital Limited, Ab Medical Centres Limited, Apollo Infrastructure Project Finance Co. Ltd., Samudra Healthcare Enterprises Limited, Imperial Cancer Hospital and Research Centre Limited and Apollo Hospital (UK) Limited. She served as a Director of Apollo Health Street Limited from February 25, 2000 to April 19, 2005. Mrs. Reddy served as a Director of The Lanka Hospitals Corporation Limited. She holds her Bachelor of Arts Degree in Economics and Marketing from the Madras University with a University Rank. She holds a Diploma in Financial Management and has completed the Owner/President Management Program at Harvard Business School, Boston, USA.
CEO Compensation
- Suneeta's compensation has been consistent with company performance over the past year.
- Suneeta's remuneration is about average for companies of similar size in India.
Management Team Tenure
Average tenure and age of the Apollo Hospitals Enterprise management team in years:
- The average tenure for the Apollo Hospitals Enterprise management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team
Prathap Reddy
Founder & Executive Chairman
₹96M
86
Suneeta Reddy
MD & Executive Director
₹38M
59
4.8 yrs
Sangita Reddy
Joint MD & Executive Director
₹37M
56
4.8 yrs
P. Reddy
Executive Vice-Chairperson
₹38M
60
Shobana Kamineni
Executive Vice Chairperson
₹39M
58
Krishnaswami Padmanabhan
Group President
₹10M
66
Krishnan Akhileswaran
Chief Financial Officer
43
Sindoori Reddy
Vice President of Operations
8.5 yrs
G. Reddy
Senior General Manager of Finance & Accounts
63
Binod Samal
Chief Technology Officer
₹4M
49
8 yrs
Board of Directors Tenure
Average tenure and age of the Apollo Hospitals Enterprise board of directors in years:
- The tenure for the Apollo Hospitals Enterprise board of directors is about average.
Board of Directors
Prathap Reddy
Founder & Executive Chairman
₹96M
86
Suneeta Reddy
MD & Executive Director
₹38M
59
18.9 yrs
Sangita Reddy
Joint MD & Executive Director
₹37M
56
18.8 yrs
P. Reddy
Executive Vice-Chairperson
₹38M
60
4.8 yrs
Shobana Kamineni
Executive Vice Chairperson
₹39M
58
4.8 yrs
Vinayak Chatterjee
Independent Director
₹2M
59
4.8 yrs
V. Dutt
Additional Independent Director
0.2 yrs
M. B. Rao
Additional Independent Director
70
0.2 yrs
T. Rajgopal
Non- Executive Independent Director
₹1M
1.9 yrs
Murali Doraiswamy
Non-Executive Independent Director
0.6 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (₹) | Value (₹) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 15. May 18 | Buy | Indian Hospitals Corporation Limited | Company | 10. May 18 | 10. May 18 | 10,184 | ₹1,031.03 | ₹10,500,000 | ||
Management checks
We assess Apollo Hospitals Enterprise's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Apollo Hospitals Enterprise has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
Why Apollo Hospitals Enterprise Limited’s (NSE:APOLLOHOSP) Use Of Investor Capital Doesn’t Look Great
To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business. … Understanding Return On Capital Employed (ROCE). … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.
Simply Wall St - – Full articleThe Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Share Price Is Up 36% And Shareholders Are Holding On
But Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) has fallen short of that second goal, with a share price rise of 36% over five years, which is below the market return. … Apollo Hospitals Enterprise's earnings per share are down 17% per year, despite strong share price performance over five years. … In contrast revenue growth of 16% per year is probably viewed as evidence that Apollo Hospitals Enterprise is growing, a real positive.
Simply Wall St - – Full articleIs Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) CEO Pay Justified?
Suneeta Reddy became the CEO of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) in 2014. … This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. … How Does Suneeta Reddy's Compensation Compare With Similar Sized Companies?
Simply Wall St - – Full articleIs Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Expensive For A Reason? A Look At The Intrinsic Value
In this article I am going to calculate the intrinsic value of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP). … by taking the expected future cash flows and discounting them to their present value. … discounted cash flows (DCF).
Simply Wall St - – Full articleWhat Kind Of Shareholders Own Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)?
A look at the shareholders of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) can tell us which group is most powerful. … With a market capitalization of ₹180b, Apollo Hospitals Enterprise is a decent size, so it is probably on the radar of institutional investors. … Check out our latest analysis for Apollo Hospitals Enterprise
Simply Wall St - – Full articleShould Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Focus On Improving This Fundamental Metric?
To keep the lesson grounded in practicality, we'll use ROE to better understand Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP). … Our data shows Apollo Hospitals Enterprise has a return on equity of 1.8% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity
Simply Wall St - – Full articleHow Financially Strong Is Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)?
Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP), with a market cap of ₹176b, are often out of the spotlight. … Don’t forget that this is a general and concentrated examination of Apollo Hospitals Enterprise’s financial health, so you should conduct further analysis. … See our latest analysis for Apollo Hospitals Enterprise
Simply Wall St - – Full articleIs Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) CEO Paid Enough Relative To Peers?
This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … How Does Suneeta Reddy's Compensation Compare With Similar Sized Companies. … Our data indicates that Apollo Hospitals Enterprise Limited is worth ₹163b, and total annual CEO compensation is ₹38m.
Simply Wall St - – Full articleEstimating The Intrinsic Value Of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Today I will be providing a simple run through of a valuation method used to estimate the attractiveness of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) as an investment opportunity. … by estimating the company's future cash flows and discounting them to their present value. … If you are reading this and its not October 2018 then I highly recommend you check out the latest calculation for Apollo Hospitals Enterprise by following the link below
Simply Wall St - – Full articleWhat Should You Know About Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) Return On Capital?
and want to begin learning the link between Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)’s return fundamentals and stock market performance. … Apollo Hospitals Enterprise stock represents an ownership share in the company. … Therefore, looking at how efficiently Apollo Hospitals Enterprise is able to use capital to create earnings will help us understand your potential return.
Simply Wall St - – Full articleCompany Info
Description
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The company’s healthcare facilities comprise primary, secondary, and tertiary care facilities. Its tertiary care hospitals provide care in approximately 55 specialties, including cardiac sciences, oncology, critical care, neurosciences, orthopedics, gastroenterology, and transplants. The company also provides other services, such as project consultancy, health insurance, education and training program, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. As of January 25, 2019, the company operated 71 hospitals with approximately 10,000 beds; 3,000 pharmacies; approximately 90 primary care and diagnostic clinics; and approximately 110 telemedicine centers. Apollo Hospitals Enterprise Limited was founded in 1979 and is headquartered in Chennai, India.
Details
| Name: | Apollo Hospitals Enterprise Limited |
| APOLLOHOSP | |
| Exchange: | NSEI |
| Founded: | 1979 |
| ₹172,918,660,121 | |
| 139,125,159 | |
| Website: | http://www.apollohospitals.com |
| Address: |
Apollo Hospitals Enterprise Limited Sunny Side Building, 3rd Floor, Chennai, Tamil Nadu, 600006, India |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NSEI | APOLLOHOSP | Equity Shares | National Stock Exchange of India | IN | INR | 10. Jan 1996 | |
| BSE | 508869 | Equity Shares | Mumbai Stock Exchange | IN | INR | 10. Jan 1996 | |
| BDL | APHOS | GDR EACH REPR 1 INR10 'REGS | Bourse de Luxembourg | LU | USD | 14. Jul 2005 |
Number of employees
Current staff
Industry
| Health Care Facilities | |
| Healthcare |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/04/24 12:47 |
| End of day share price update: | 2019/04/24 00:00 |
| Last estimates confirmation: | 2019/04/22 |
| Last earnings filing: | 2018/09/11 |
| Last earnings reported: | 2018/03/31 |
| Last annual earnings reported: | 2018/03/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
